LB Pharmaceuticals Inc
LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in New York, NY, focused on developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia and bipolar depression. The company's lead product candidate, LB102, is positioned to potentially become the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States.
The firm is actively building a pipeline that leverages the broad therapeutic potential of LB102, informed by peer-reviewed research and presentations. As LB Pharmaceuticals Inc advances its clinical efforts, it seeks to address unmet needs in mental health treatment through innovative approaches.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
